Publications by authors named "Raymond Schlienger"

Claim this Profile
H
Hospitalization Rates in Patients with Heart Failure and Reduced Ejection Fraction Initiating Sacubitril/Valsartan or Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: A Retrospective Cohort Study.
Emma Houchen, Emil Loefroth, Raymond Schlienger, Clare Proudfoot, Stefano Corda

Cardiol Ther· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physician adjudication of angioedema diagnosis codes in a population of patients with heart failure prescribed angiotensin-converting enzyme inhibitor therapy.
Elizabeth T Mansi, Eric S Johnson, Micah L Thorp, Alan S Go, Ming-Sum Lee, Raymond G Schlienger

Pharmacoepidemiol Drug Saf· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heart failure signs and symptoms, hospital referrals, and prescription patterns in patients receiving sacubitril/valsartan in primary care and cardiologist settings in Germany.
Rolf Wachter, Sven Klebs, Bogdan Balas, Elisabeth Kap, Johanna Engelhard, Raymond Schlienger

ESC Heart Fail· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk reduction of diarrhea and respiratory infections following a community health education program - a facility-based case-control study in rural parts of Kenya.
Miriam Karinja, Raymond Schlienger, Goonaseelan Colin Pillai, Tonya Esterhuizen, Evance Onyango

BMC Public Health· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between vildagliptin and risk of angioedema, foot ulcers, skin lesions, hepatic toxicity, and serious infections in patients with type 2 diabetes mellitus: A European multidatabase, noninterventional, postauthorization safety study.
Rachael Williams, Wolfgang Kothny, Carmen Serban, Sandra Lopez-Leon, Frank de Vries, Raymond Schlienger

Endocrinol Diabetes Metab· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Care-Seeking Dynamics among Patients with Diabetes Mellitus and Hypertension in Selected Rural Settings in Kenya.
Miriam Karinja, Goonaseelan Pillai, Raymond Schlienger, Marcel Tanner, Bernhards Ogutu

Int J Environ Res Public Health· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world treatment patterns of sacubitril/valsartan: a longitudinal cohort study in Germany.
Rolf Wachter, Ana F Fonseca, Bogdan Balas, Elisabeth Kap, Johanna Engelhard, Raymond Schlienger

Eur J Heart Fail· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreatic safety of vildagliptin in patients with type 2 diabetes mellitus: A European, noninterventional, postauthorization safety study.
Rachael Williams, Wolfgang Kothny, Carmen Serban, Sandra Lopez-Leon, Raymond Schlienger

Endocrinol Diabetes Metab· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology of heart failure and trends in diagnostic work-up: a retrospective, population-based cohort study in Sweden.
Krister Lindmark, Kurt Boman, Mona Olofsson, Michael Törnblom, Aaron Levine, Raymond Schlienger

Clin Epidemiol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of early sacubitril/valsartan patients and considerations for studies in electronic health record data.
Joshua J Gagne, Theodore Tsacogianis, Sara Bruce Wirta, James R Rogers, Frederico Calado, Raymond G Schlienger

J Comp Eff Res· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Database Cohort Study to Assess the Risk of Angioedema Among Patients with Heart Failure Initiating Angiotensin-Converting Enzyme Inhibitors in the USA.
Thy P Do, Arpamas Seetasith, Rossella Belleli, Raymond G Schlienger, Stefano Corda

Am J Cardiovasc Drugs· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early insights into the characteristics and evolution of clinical parameters in a cohort of patients prescribed sacubitril/valsartan in Germany.
Rolf Wachter, Daniel Viriato, Sven Klebs, Stefanie S Grunow, Matthias Schindler, Raymond Schlienger

Postgrad Med· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angioedema Among Hypertensive Patients Treated with Aliskiren or Other Antihypertensive Medications in the United States.
Raymond G Schlienger, Jonathan R Korn, Elizabeth Wehler, Sandra Lopez Leon, Jason Yeaw

Am J Cardiovasc Drugs· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular safety of vildagliptin in patients with type 2 diabetes: A European multi-database, non-interventional post-authorization safety study.
Rachael Williams, Frank de Vries, Wolfgang Kothny, Carmen Serban, Sandra Lopez-Leon, Raymond Schlienger

Diabetes Obes Metab· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): a methodological approach to assess consistencies across databases from the PROTECT-EU project.
Gema Requena, Consuelo Huerta, Helga Gardarsdottir, John Logie, Rocío González-González, Raymond Schlienger

Pharmacoepidemiol Drug Saf· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do case-only designs yield consistent results across design and different databases? A case study of hip fractures and benzodiazepines.
Gema Requena, John Logie, Elisa Martin, Nada Boudiaf, Rocío González González, Raymond Schlienger

Pharmacoepidemiol Drug Saf· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project.
Consuelo Huerta, Victoria Abbing-Karahagopian, Gema Requena, Belén Oliva, Yolanda Alvarez, Raymond G Schlienger

Pharmacoepidemiol Drug Saf· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of antibiotic use: a comparison across various European health care data sources.
Ruth Brauer, Ana Ruigómez, Gerry Downey, Andrew Bate, Luis Alberto Garcia Rodriguez, Raymond Schlienger

Pharmacoepidemiol Drug Saf· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The IMI PROTECT project: purpose, organizational structure, and procedures.
Robert F Reynolds, Xavier Kurz, Mark C H de Groot, Raymond G Schlienger, Lamiae Grimaldi-Bensouda

Pharmacoepidemiol Drug Saf· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of acute liver injury associated with use of antibiotics. Comparative cohort and nested case-control studies using two primary care databases in Europe.
Ruth Brauer, Ian Douglas, Luis Alberto Garcia Rodriguez, Gerald Downey, Consuelo Huerta, Raymond Schlienger

Pharmacoepidemiol Drug Saf· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding inconsistency in the results from observational pharmacoepidemiological studies: the case of antidepressant use and risk of hip/femur fractures.
Patrick C Souverein, Victoria Abbing-Karahagopian, Elisa Martin, Consuelo Huerta, Francisco de Abajo, Raymond G Schlienger

Pharmacoepidemiol Drug Saf· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case-only designs for studying the association of antidepressants and hip or femur fracture.
Mark C H de Groot, Gianmario Candore, Md Jamal Uddin, Patrick C Souverein, M Sanni Ali, Raymond G Schlienger

Pharmacoepidemiol Drug Saf· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-centre, multi-database studies with common protocols: lessons learnt from the IMI PROTECT project.
Olaf H Klungel, Xavier Kurz, Mark C H de Groot, Raymond G Schlienger, Stephanie Tcherny-Lessenot

Pharmacoepidemiol Drug Saf· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time trends of period prevalence rates of patients with inhaled long-acting beta-2-agonists-containing prescriptions: a European comparative database study.
Marietta Rottenkolber, Eef Voogd, Liset van Dijk, Paola Primatesta, Claudia Becker, Raymond Schlienger

PLoS One· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis